The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
Abstract
A novel class of synthetic peptides has been designed that inhibit the thrombin catalytic site and exhibit specificity for the anion-binding exosite (ABE) of alpha-thrombin. These peptides, called "hirulogs", consist of (i) an active-site specificity sequence with a restricted Arg-Pro scissile bond, (ii) a polymeric linker of glycyl residues from 6 to 18 A in length, and (iii) an ABE recognition sequence such as that in the hirudin C-terminus. Hirulog-1 ([D-Phe)-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Glu-Ile- Pro-Glu-Tyr-Leu] inhibits the thrombin-catalyzed hydrolysis of a tripeptide p-nitroanilide substrate with Ki = 2.3 nM. In contrast, the synthetic C-terminal hirudin peptide S-Hir53-64, which binds to the thrombin ABE, blocked the fibrinogen clotting activity of the enzyme with Ki = 144 nM but failed to inhibit the hydrolysis of p-nitroanilide substrates at concentrations as high as 1 mM. In addition, the pentapeptide (D-Phe)-Pro-Arg-Pro-Gly, which comprises the catalytic-site inhibitor moiety of hirulog-1, was determined to have a Ki for thrombin inhibition greater than 2 microM. Hirulog-1, but not S-Hir53-64, was found to inhibit the incorporation of [14C]diisopropyl fluorophosphate in thrombin. Hirulog-1 appears specific for thrombin as it lacks inhibitory activities toward human factor Xa, human plasmin, and bovine trypsin at inhibitor:enzyme concentrations 3 orders of magnitude higher than those required to inhibit thrombin. The optimal inhibitory activity of hirulog-1 depends upon all three components of its structure.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Automatic Recording Apparatus for Use in Chromatography of Amino Acids
Spackman, D. H., Stein, W. H., & Moore, S. (1958) · Analytical Chemistry · doi:10.1021/ac60139a006 · Cited by 9,585
Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R., & Hofsteenge, J. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08511.x · Cited by 888
Kinetics of the inhibition of thrombin by hirudin
Stone, S. R., & Hofsteenge, J. (1986) · Biochemistry · doi:10.1021/bi00364a025 · Cited by 586
Furie, B., Bing, D. H., Feldmann, R. J., Robison, D. J., Burnier, J. P., & Furie, B. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34864-6 · Cited by 220
Anion-binding exosite of human .alpha.-thrombin and fibrin(ogen) recognition
Fenton, J. W., Olson, T. A., Zabrinski, M. P., & Wilner, G. D. (1988) · Biochemistry · doi:10.1021/bi00418a066 · Cited by 159
Self-citationINHIBITION OF THROMBIN AND TRYPSIN BY TRIPEPTIDE ALDEHYDES
Bajusz, S., Barabás, É., Tolnay, P., Szell, E., & Bagdy, D. (1978) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1978.tb02889.x · Cited by 142
The clotting of fibrinogen II. Fractionation of peptide material liberated
Bettelheim, F. R. (1956) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(56)90393-6 · Cited by 124
Cited by
Peptidomimetics—Tailored Enzyme Inhibitors
Gante, J. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199416991 · Cited by 825
Hirsh, J., Bauer, K. A., Donati, M. B., Gould, M., Samama, M. M., & Weitz, J. I. (2008) · Chest · doi:10.1378/chest.08-0689 · Cited by 755
Di Nisio, M., Middeldorp, S., & Büller, H. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044440 · Cited by 655
Proteinase-Activated Receptors
Macfarlane, S. R., Seatter, M. J., Kanke, T., Hunter, G. D., & Plevin, R. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01493-5 · Cited by 641
Bode, W., Turk, D., & Karshikov, A. (1992) · Protein Science · doi:10.1002/pro.5560010402 · Cited by 627
Metadata
- Authors
- Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., & Fenton, J. W.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1990-07-31
- Volume
- 29
- Issue
- 30
- Pages
- 7095-7101
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2162356386
- Cited by
- 466
- References
- 7
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. https://app.cochat.ai/papers/10.1021/bi00482a021
- The paper
- Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., & Fenton, J. W. (1990). Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry. https://doi.org/10.1021/bi00482a021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.